Ibuprofen and Neural Mobilization Treatment in Carpal Tunnel Syndrome. (NCT04328805) | Clinical Trial Compass
CompletedPhase 4
Ibuprofen and Neural Mobilization Treatment in Carpal Tunnel Syndrome.
Venezuela123 participantsStarted 2020-09-23
Plain-language summary
In the present investigation, the pain reduction effect of median nerve neural mobilization and oral ibuprofen treatments will be compared to those produced by the absence of treatment, in subjects who suffer the signs and symptoms of carpal tunnel syndrome.
Who can participate
Age range18 Years ā 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with confirmative electrodiagnostic findings).
* Full understanding of written and spoken Spanish (language).
* Participants must freely consent to participate.
* The presence of positive Phalen and Tinel signs.
* The presence of carpal tunnel syndrome signs and symptoms.
Exclusion Criteria:
* The lack to meet inclusion criterions.
* The presence of cognitive impairment.
* Tumors.
* Cancer.
* Upper limb surgery or trauma.
* Pregnancy.
* Deformities of the (affected) upper limb.
* Recent skin injuries or infections (in the affected upper limb).
* Autoimmune inflammatory conditions or flu type symptoms.
* Allergy (or contraindication) to non steroidal anti inflammatory drugs (NSAID)
* Participants must not be (during the present investigation) under any type of pain reducing treatment (conservative, homeopathic, invasive or not invasive).
* Metabolic neuropathy.
* Obesity (body mass index over 30).
* Participants who are not employed.
What they're measuring
1
Distal upper limb pain
Timeframe: Changes from baseline (measured immediately before the application of the first treatment) and 60 minutes after the application of the last treatment.